Press Release May 15 2025

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 15, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg".

View Attachment